Delivery Order SPE2DB20D2001-SPE2DB25FPLVN

Award Date 1/14/25
Potential Completion Date 2/5/25
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,771.04 firm-fixed-price delivery order contract is for the provision of the medication ORGOVYX 120 MG TABLET, with a performance period through June 2, 2025. The award is not designated as a set-aside and represents an open competition. Amerisourcebergen Drug Corp is the prime contractor, with no major...
This federal contract award, SPE2DB20D2001|SPE2DB25FPMKE, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 Firm Fixed Price Delivery Order contract is for the supply of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 Firm Fixed Price Delivery Order contract is for the supply of ORGOVYX 120 MG TABLET UU 30S, a pharmaceutical product. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $8,313.12 firm fixed-price delivery order is for the medication ORGOVYX 120 MG TABLET, with a period of performance through May 13, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 fixed-price delivery order is for ORGOVYX 120 MG TABLET, a pharmaceutical product. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,659.78 firm fixed-price delivery order is for the supply of the medication ORGOVYX 120 MG TABLET UU 30S, with a completion date of December 5, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award, with the ID SPE2DB22D1017|SPE2DB25FF4PF, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,156.56 firm fixed-price delivery order is for the supply of ORGOVYX 120 MG TABLET, a pharmaceutical product, to support federal healthcare programs. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,503.40 firm-fixed-price delivery order is for the medication ORGOVYX 120 MG TABLET UU 30S, with a completion date of January 9, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm fixed-price delivery order is for the medication ORGOVYX 120 MG TABLET, with a performance period through March 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of...
This federal contract award, with ID SPE2DB22D2206|SPE2DB25FGR17, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,385.52 firm-fixed-price delivery order is for the medication ORGOVYX 120 MG TABLET, with a performance period ending on May 12, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract...
  • SPE2DB20D2001
    Indefinite Delivery Contract
  • SPE2DB20D2001-SPE2DB25FPLVN
    Delivery Order

This federal contract award, with ID SPE2DB20D2001|SPE2DB25FPLVN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,375.85 firm fixed-price delivery order is for the medication ORGOVYX 120 MG TABLET UU 30S.

The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This IDC covers critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen is the prime contractor, and there is no information provided about major subcontractors. The funding agency is the Defense Logistics Agency, a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces.

Generated 5/21/25, 10:15 AM